Literature DB >> 2154554

Phosphorylation of the rat skeletal muscle sodium channel by cyclic AMP-dependent protein kinase.

J Yang1, R Barchi.   

Abstract

Cyclic AMP-dependent phosphorylation of the rat brain sodium channel was reported to be restricted to five sites within an approximately 210 amino acid region of the primary sequence that is deleted in the homologous sodium channel from rat skeletal muscle. We find that, in spite of this deletion, the rat muscle sodium channel alpha-subunit is also an excellent substrate for phosphorylation by this kinase both in primary muscle cells in tissue culture and in vitro after isolation from adult muscle. Sodium channel protein purified from adult rat skeletal muscle was readily phosphorylated in vitro by the catalytic subunit of the bovine cyclic AMP-dependent protein kinase (PKa). Only the 260,000 MW alpha-subunit was labeled, with a maximum level of incorporation in vitro of approximately 0.5 mol [32P]phosphate per mole of channel protein. The beta-subunit of the channel is not phosphorylated under these conditions. In primary rat skeletal muscle cells in culture, incorporation of phosphate into the channel alpha-subunit is stimulated 1.3- to 1.5-fold by treatment of the cells with forskolin. Phosphorylation of the sodium channel isolated from these cells could also be demonstrated in vitro using PKa. This in vitro phosphorylation could be inhibited 80-90% by pretreatment of the cells in culture with forskolin, suggesting that the sites labeled in vitro by PKa were the same as those phosphorylated in the intact cells by the endogenous cyclic AMP-dependent kinase. In both the adult muscle channel and the channel from muscle cells in culture, phosphorylation by PKa was limited to serine residues.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154554     DOI: 10.1111/j.1471-4159.1990.tb02343.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Localization of epitopes for antibodies that differentially label sodium sodium channels in skeletal muscle surface and T-tubular membranes.

Authors:  S A Cohen; R L Barchi
Journal:  J Membr Biol       Date:  1992-06       Impact factor: 1.843

Review 2.  β-Adrenergic modulation of skeletal muscle contraction: key role of excitation-contraction coupling.

Authors:  Simeon P Cairns; Fabio Borrani
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

3.  Modulation of skeletal and cardiac voltage-gated sodium channels by calmodulin.

Authors:  Katharine A Young; John H Caldwell
Journal:  J Physiol       Date:  2005-03-03       Impact factor: 5.182

Review 4.  Structure and function of voltage-gated sodium channels.

Authors:  E Marban; T Yamagishi; G F Tomaselli
Journal:  J Physiol       Date:  1998-05-01       Impact factor: 5.182

Review 5.  Structure, function and expression of voltage-dependent sodium channels.

Authors:  R G Kallen; S A Cohen; R L Barchi
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

6.  Sodium channel isoform-specific effects of halothane: protein kinase C co-expression and slow inactivation gating.

Authors:  M K Patel; D Mistry; J E John; J P Mounsey
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 7.  Regulation of sodium channel activity by phosphorylation.

Authors:  Todd Scheuer
Journal:  Semin Cell Dev Biol       Date:  2010-10-13       Impact factor: 7.727

8.  Diacylglycerol-induced activation of protein kinase C attenuates Na+ currents by enhancing inactivation from the closed state.

Authors:  C M Godoy; S Cukierman
Journal:  Pflugers Arch       Date:  1994-12       Impact factor: 3.657

9.  Multiple effects of protein kinase C activators on Na+ currents in mouse neuroblastoma cells.

Authors:  C M Godoy; S Cukierman
Journal:  J Membr Biol       Date:  1994-06       Impact factor: 1.843

10.  Modulation of skeletal muscle sodium channels by human myotonin protein kinase.

Authors:  J P Mounsey; P Xu; J E John; L T Horne; J Gilbert; A D Roses; J R Moorman
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.